John Greene Crispr Therapeutics Ag (CRSP) insider trading activity

CRSP Quotes by TradingView

John Greene is of CRISPR Therapeutics AG. Currently has a direct ownership of 7,000 shares of CRSP, which is worth approximately $238,210. The most recent transaction as insider was on Feb 26, 2025, when has been sold 7,000 shares (Common Shares) at a price of $44.85 per share, resulting in proceeds of $313,950. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7K
n/a 3M change
n/a 12M change
Total Value Held $238,210

John Greene Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 26 2025
BUY
Open market or private purchase
$313,950 $44.85 p/Share
7,000 Added 50.0%
7,000 Common Shares

Also insider at

DFS
Discover Financial Services Financial Services
EVP, Chief Financial Officer
JG

John Greene

Cambridge, MA

Track Institutional and Insider Activities on CRSP

Follow CRISPR Therapeutics AG and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRSP shares.

Notify only if

Insider Trading

Get notified when an Crispr Therapeutics Ag insider buys or sells CRSP shares.

Notify only if

News

Receive news related to CRISPR Therapeutics AG

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CRSP